- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05071456
Electrochemistry Measurement of Skin Hydration Parameters (SKINBIOSENSE)
Pilot Study Assessing the Feasibility and Reliability of Measurements of Skin's Parameters Hydration by Electrochemistry
To date measuring the effect of dermocosmetic products on the main identified factors of aging and alteration of the skin barrier is based on invasive and expensive experiments. Electrochemistry enables to measure a specific signal for a substance of interest e.g. Vitamin C using an surface contact with an electrode.
Therefore, this study will evaluate the reliability and feasibility of measurements of skin's hydration parameters such as NMF and squalene using electrochemistry. These study will be made on three groups of individuals with different skin types: dry skin i.e. atopic dermatitis patients, oily skin i.e. acne skin and a control group of individual without facial dermatosis. Collects of parameters of interest will be made by using patch using electrochemistry (contact with an electrode and potentiostat to detect an electric signal) . It is a simple method that relies on a sensor / electrode pair that allows a study of the surface molecules of the skin. Application in the measurement of vitamin C in food products has already been validated.
On a second hand, a collect by chromatography of the parameters of interest will be carried out in order to compare the new method with the reference method.
This procedure has been developed via a procedure including collecting surface parameters using a patch an developping special electrodes and miniaturized detecting signal tool (potentiostat)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tu Anh Duong, MD PhD
- Phone Number: + 33 01 49 09 44 29
- Email: tu-anh.duong@aphp.fr
Study Contact Backup
- Name: David Schmitz
- Phone Number: + 33 01 49 81 36 32
- Email: david.schmitz@aphp.fr
Study Locations
-
-
-
Créteil, France, 94040 Créteil Cedex
- Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
-
Contact:
- Tu Anh Duong, MD PhD
- Phone Number: + 33 01 49 09 44 29
- Email: tu-anh.duong@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 ≤ Age ≤ 70
- Subjects with past history or follow-up for acne or rosacea stage I ou II, atopic dermatitis mild to moderate without immunosuppressive treatment
- Subjects enabling to perform a one day visit at the hospital
- Written consent according to local regulatory requirements
- Affiliated to a social security scheme
Exclusion Criteria:
- Pregnant women or breastfeeding
- Patient under guardianship or curatorship, legal protection or protection of justice
- Participation in other interventional research on skin moisturizer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Atopic dermatitis patients
|
Collects of skin's hydration will be made by using patch using electrochemistry.
|
|
Experimental: Patient with oily acne skin
|
Collects of skin's hydration will be made by using patch using electrochemistry.
|
|
Active Comparator: Control group of patient without facial dermatosis
|
Collects of skin's hydration will be made by using patch using electrochemistry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of collecting an electrochemical measure of skin hydration parameter (natural moisturizer factor electric signal) at two different sites of the face at T0 using patch and electrode
Time Frame: Day 0 or Day 1
|
Feasibility of collecting an electrochemical measure of skin hydration parameter (natural moisturizer factor electric signal) at two different sites of the face at T0 using patch and electrode.
Signal detection (mVolt) or not using a patch to collect skin surface parameter applied on an electrode to collect and electric signal.
|
Day 0 or Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validation of the measure process for different skin type e.g: dry, oily, normal
Time Frame: Day 0 or Day 1
|
Rate of failure by site or skin type, obtained measure mean and SD for all and regarding each group
|
Day 0 or Day 1
|
|
Determine the correlation between electrochemistry measures or skin hydration (level of electrical signal mvolt ) and reference method: corneometry or chromatography.
Time Frame: Day 0 or Day 1
|
Those two methods are routinely used to asses skin hydration using a swab contact then migration in a chromatography column or use of sebumeter Correlation coefficient between level of electrochemical measure (signal) regarding skin types and measures issued from reference methodology (corneometry or chromatography)
|
Day 0 or Day 1
|
|
Describe individuals' habits or daily routine for skin care using a questionnairemethodology (corneometry or chromatography)
Time Frame: Day 0 or Day 1
|
Descriptive statistics: smoke, sun exposure, moisturizer use
|
Day 0 or Day 1
|
Collaborators and Investigators
Investigators
- Study Director: Tu Anh Duong, MD PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210446
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atopic Dermatitis
-
Caja Costarricense de Seguro SocialNot yet recruitingAtopic Dermatitis | Atopic Dermatitis (Eczema) | Atopic Dermatitis (AD) | Atopic Dermatitis / Eczema | Atopic Dermatitis, Unspecified | Atopic Dermatitis PatientsCosta Rica
-
Alphyn BiologicsRecruitingEczema | Atopic Dermatitis | Atopic Dermatitis (Eczema) | Atopic Dermatitis Eczema | Eczema, Atopic | Atopic Dermatitis (AD)Australia
-
En Chu Kong HospitalRecruitingSkin Diseases | Skin Diseases, Genetic | Skin Diseases, Eczematous | Atopic Dermatitis | Atopic Dermatitis (Eczema) | Atopic Dermatitis Eczema | Atopic Dermatitis (AD) | TCMTaiwan
-
Catalysis SLCompletedAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions | Atopic Dermatitis \(AD\)Serbia
-
Taipei Medical University Shuang Ho HospitalRecruitingAtopic Dermatitis (Eczema) | Atopic Dermatitis, ProbioticsTaiwan
-
Jacob Pontoppidan ThyssenThe Novo Nordic FoundationRecruitingAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis FlareDenmark
-
Apollo Therapeutics LtdRecruitingDermatitis | Eczema | Dermatitis, Atopic | Atopic Dermatitis | Atopic | Eczema, Atopic | Dermatologic Disease | Eczema Atopic DermatitisUnited States, Spain, Germany, Canada, Bulgaria, Poland, Czechia, Hungary
-
PfizerTerminatedEczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, UnspecifiedUnited States, Canada, Czechia, Poland
-
Corvus Pharmaceuticals, Inc.RecruitingEczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Eczema, AtopicUnited States
-
Evommune, Inc.CompletedEczema | Atopic Dermatitis (AD) | Eczema Atopic DermatitisNew Zealand, Australia
Clinical Trials on Collects of skin's hydration
-
National Taiwan University HospitalRecruitingPalliative Medicine | Hospice | Terminal CancerTaiwan
-
Northwestern UniversityCompleted
-
Guangdong Provincial People's HospitalPeking University First Hospital; Fudan University; Chinese PLA General HospitalUnknown
-
Massachusetts Institute of TechnologyBoston Children's Hospital; National Institutes of Health (NIH); National Institute...CompletedDehydrationUnited States
-
Medical University of ViennaCompleted
-
University Hospital, CaenUnknownElectric Impedance | Chronic Kidney Disease Requiring Chronic Dialysis | Hemodialysis, HomeFrance
-
Osprey Medical, IncTerminatedRadiographic Contrast Agent NephropathyUnited States, Germany
-
University of AlbertaAlberta Heritage Foundation for Medical ResearchCompletedAcute Renal Failure | Chronic Renal Failure | Contrast-induced NephropathyCanada
-
Peking University First HospitalAerospace Center HospitalCompletedPostoperative Complications | Acute Kidney Injury | Cytoreductive Surgery | Hydration | Diuresis | Hyperthermic Intraperitoneal ChemotherapyChina